Visory Health delivers $790 million in savings on critical cardiovascular medications
Benefiting over 1.5 million cardiovascular patients, prescription discount cards help reduce a key financial barrier.
Benefiting over 1.5 million cardiovascular patients, prescription discount cards help reduce a key financial barrier.
The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy.
Suicide is now the second leading cause of death among young people 10-14 years old and the third leading cause of death for those between the ages of 15 and 24.
CEO Mark Newman explains how retail pharmacies are becoming central to care delivery and the direct-pay model reshaping health care.
After pushback on regulators’ interpretation of A.B. 899, lawmakers confirmed that dietary supplements are distinct from baby food and exempt from duplicative testing.
RxSmartSaver powered by GoodRx delivers instant affordability at the pharmacy counter, giving consumers easier access to savings on widely used brand-name medications.
Although $200 is a steep monthly co-pay for a covered brand-name medication, it’s still significantly lower than the $500 price Novo Nordisk charges through its direct-to-consumer platform for uninsured individuals.
By Harini Bupathi, Esq. partner, Frier Levitt’s Life Sciences Group
New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action.
Investment strengthens local organizations to advance food access, workforce development, and housing stability in underserved communities.
Leveraging the strength of the CVS Health family of companies to deliver differentiated member experiences.
Voluntary agreement meets the President’s four requests while also protecting the U.S. ecosystem responsible for America’s leadership in delivering medical breakthroughs.
“The President’s announcement reflects the reality that pharmacy benefit manager (PBM) tactics are exploding Americans’ prescription drug costs, and this action is an attempt to strike a blow against the PBMs’ manipulation and self-enrichment in the prescription drug supply chain."
FDA declined to issue guidance or rulemaking, which CRN said will stifle innovation and perpetuate conflict between supplement makers and pharmaceutical companies.
The US is the largest market for APIs, fueled by high drug use, strong regulation, and top biotech manufacturing.
The state-of-the-art forward distribution center will feature automation and the latest technology advancements in support of the segment's distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States.